BAVARIAN NORDIC INC. for BAVARIAN NORDIC INC.
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Health Issues HCR
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Medical/Disease Research/Clinical Labs MED
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Pharmacy PHA
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Defense DEF
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Homeland Security HOM
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Science/Technology SCI
Biodefense, Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing, infectious diseases, cancer, PAHPA, Labor-HHS Appropriations bills
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK LENKER New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BAVARIAN NORDIC A/S | Denmark | Denmark | 100.0% | $250,000 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.